A thiadiazolidinone analog that acts as a highly selective, non-ATP competitive inhibitor of GSK-3be
REVIEW GSK-3beta Inhibitor I is a thiadiazolidinone (TDZD) analog that acts as a highly selective, non-ATP competitive inhibitor of GSK-3beta (IC50 = 2 µM). GSK-3beta Inhibitor I inhibits PKC and Flt-3 activities (IC50 = 1.4-5.5 µM and 673 nM, respectively). GSK-3beta Inhibitor I does not significantly affect the activities of Cdk-1/cyclin B, CK-II, and PKA, (IC50 > 100 µM). This compound binds to the active site of GSK-3beta.
All products are stocked and shipped from the SF Bay, California, USA via FedEx, UPS or DHL.
All batches backed with full quality assurance.
⚠️
All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.
These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.
Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.
New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.
Add to Favorites 
Delete from Favorites 
